Table 3.
Before TS | After TS | |||
---|---|---|---|---|
|
||||
Value | 95% CI | Value | 95% CI | |
CHF | ||||
Sensitivity, % | 73.3 | 44.9–92.2 | 100.0 | 78.2–100.0 |
Specificity, % | 78.6 | 63.2–89.7 | 95.2 | 83.8–99.4 |
LR positive | 3.4 | 1.8–6.6 | 21.0 | 5.4–81.2 |
LR negative | 0.3 | 0.1–0.8 | 0.0 | 0.0–0.5 |
COPD/Asthma | ||||
Sensitivity, % | 76.5 | 50.1–93.2 | 64.7 | 38.3–85.8 |
Specificity, % | 80.0 | 64.4–90.9 | 93.3 | 77.9–99.2 |
LR positive | 3.8 | 2.0–7.5 | 9.7 | 2.4–38.7 |
LR negative | 0.3 | 0.1–0.7 | 0.4 | 0.2–0.7 |
Pneumonia | ||||
Sensitivity, % | 31.2 | 11.0–58.7 | 100.0 | 78.2–100 |
Specificity, % | 90.2 | 76.9–97.3 | 82.9 | 67.9–92.8 |
LR positive | 3.2 | 0.98–10.44 | 5.9 | 3.0–11.5 |
LR negative | 0.76 | 0.54–1.08 | 0.0 | 0.0–0.5 |
CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; LR, likelihood ratio